Biohit Oyj (HEL: BIOBV)
Finland
· Delayed Price · Currency is EUR 2.170
+0.060 (2.84%)
Aug 30, 2024, 6:11 PM EET
Biohit Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 13.98 | 13.08 | 10.95 | 9.36 | 7.12 | 10.05 | Upgrade
|
| Revenue Growth (YoY) | 23.13% | 19.40% | 16.99% | 31.42% | -29.14% | 1.22% | Upgrade
|
| Cost of Revenue | 5.41 | 4.61 | 3.84 | 3.45 | 3.17 | 3.39 | Upgrade
|
| Gross Profit | 8.56 | 8.46 | 7.11 | 5.92 | 3.96 | 6.67 | Upgrade
|
| Selling, General & Admin | 4.19 | 4.09 | 3.63 | 3.45 | 3.06 | 3.29 | Upgrade
|
| Other Operating Expenses | 2.29 | 2.19 | 1.87 | 1.98 | 2.07 | 2.78 | Upgrade
|
| Operating Expenses | 6.84 | 6.64 | 5.98 | 7.42 | 7.13 | 8.08 | Upgrade
|
| Operating Income | 1.73 | 1.83 | 1.13 | -1.5 | -3.17 | -1.41 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.03 | 0.03 | -0.01 | 0.02 | -0.01 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.21 | 0.41 | -0.29 | 0.09 | -0.16 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | 1.96 | 2.26 | 0.83 | -1.39 | -3.34 | -1.39 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.07 | -0.07 | 0.04 | 0.06 | 0.08 | 0.16 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.02 | - | - | Upgrade
|
| Pretax Income | 1.9 | 2.2 | 0.87 | -1.31 | -3.26 | -1.23 | Upgrade
|
| Income Tax Expense | 0.24 | 0.34 | 0.27 | 0.2 | 0.05 | 0.19 | Upgrade
|
| Earnings From Continuing Operations | 1.65 | 1.85 | 0.6 | -1.5 | -3.31 | -1.42 | Upgrade
|
| Net Income | 1.65 | 1.85 | 0.6 | -1.5 | -3.31 | -1.42 | Upgrade
|
| Net Income to Common | 1.65 | 1.85 | 0.6 | -1.5 | -3.31 | -1.42 | Upgrade
|
| Net Income Growth | 49.95% | 207.99% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 0.51% | 0.41% | 0.13% | - | 0.27% | -0.07% | Upgrade
|
| EPS (Basic) | 0.11 | 0.12 | 0.04 | -0.10 | -0.22 | -0.09 | Upgrade
|
| EPS (Diluted) | 0.11 | 0.12 | 0.04 | -0.10 | -0.22 | -0.09 | Upgrade
|
| EPS Growth | 55.70% | 200.41% | - | - | - | - | Upgrade
|
| Free Cash Flow | -0.55 | 0.65 | 1.79 | -0.48 | -0.04 | 0.04 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | 0.04 | 0.12 | -0.03 | -0.00 | 0.00 | Upgrade
|
| Gross Margin | 61.28% | 64.73% | 64.94% | 63.19% | 55.57% | 66.33% | Upgrade
|
| Operating Margin | 12.34% | 13.96% | 10.30% | -16.02% | -44.56% | -14.06% | Upgrade
|
| Profit Margin | 11.81% | 14.16% | 5.49% | -16.02% | -46.51% | -14.10% | Upgrade
|
| Free Cash Flow Margin | -3.91% | 5.00% | 16.34% | -5.10% | -0.56% | 0.37% | Upgrade
|
| EBITDA | 1.83 | 1.93 | 1.34 | 0.23 | -1.39 | 0.38 | Upgrade
|
| EBITDA Margin | 13.12% | 14.78% | 12.24% | 2.46% | -19.51% | 3.75% | Upgrade
|
| D&A For EBITDA | 0.11 | 0.11 | 0.21 | 1.73 | 1.78 | 1.79 | Upgrade
|
| EBIT | 1.73 | 1.83 | 1.13 | -1.5 | -3.17 | -1.41 | Upgrade
|
| EBIT Margin | 12.34% | 13.96% | 10.30% | -16.02% | -44.56% | -14.06% | Upgrade
|
| Effective Tax Rate | 12.88% | 15.67% | 30.76% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.